Clinical trial
Primary Aldosteronism In Hypertensive Patients in China
NCT03155139
Study timeline
Study start (actual)2017-06-03Date precision: day
Registry last updated2020-10-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hyperaldosteronism; Primaryunresolved
Hypertension Secondaryunresolved
Interventions
Aldosterone/renin ratio (ARR) testingDIAGNOSTIC_TEST
Confirmatory testsDIAGNOSTIC_TEST
Sponsors & collaborators
Qifu Lilead sponsor
Fu Wai Hospital, Beijing, Chinacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03155139 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.